TERT and neoplasm: In our previous study, we have established a single-gene assay based on the Ion Torrent Proton system (UroMuTERT) for the quantification of tumor-derived TERT promoter mutations load in urine cellDNA or cell-free DNA and evaluated its clinical performance in the DIAGURO and IPO-PORTO case-control studies [11].